$KRON
Kronos Bio, Inc. Stock $kron

$kron Overview Financials Valuation SEC Filings Company Website

2022 Q3 Form 10-Q Financial Statement

#000174183022000026 Filed on August 04, 2022

Income Statement

Concept	2022 Q3	2022 Q2	2022 Q1
Revenue	$0.00	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$10.90M	$11.59M	$12.69M
YoY Change	11.79%	14.69%	32.37%
% of Gross Profit
Research & Development	$23.40M	$22.71M	$24.44M
YoY Change	-5.2%	14.67%	38.9%
% of Gross Profit
Depreciation & Amortization	$600.0K	$600.0K	$600.0K
YoY Change	20.0%	20.0%	50.0%
% of Gross Profit
Operating Expenses	$33.54M	$33.53M	$36.37M
YoY Change	-0.4%	15.06%	38.91%
Operating Profit	-$33.54M	-$33.53M	-$36.37M
YoY Change	-0.4%	15.06%	38.91%
Interest Expense	$1.282M	$627.0K	$102.0K
YoY Change
% of Operating Profit
Other Income/Expense, Net	$1.282M	$627.0K	$102.0K
YoY Change	1731.43%	629.07%	10.87%
Pretax Income	-$32.26M	-$32.90M	-$36.26M
YoY Change	-4.01%	13.24%	38.99%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$32.26M	-$32.90M	-$36.26M
YoY Change	-4.01%	13.24%	39.01%
Net Earnings / Revenue
Basic Earnings Per Share	-$0.57	-$0.59	-$0.65
Diluted Earnings Per Share	-$0.57	-$0.59	-$0.65
COMMON SHARES
Basic Shares Outstanding	56.77M shares	56.12M shares	55.84M shares
Diluted Shares Outstanding	56.32M shares	56.12M shares	55.84M shares

Balance Sheet

Concept	2022 Q3	2022 Q2	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$258.3M	$267.9M	$303.1M
YoY Change	-35.17%	-35.74%	-24.01%
Cash & Equivalents	$67.48M	$86.14M	$149.0M
Short-Term Investments	$190.8M	$181.7M	$154.2M
Other Short-Term Assets	$5.768M	$6.341M	$6.794M
YoY Change	69.8%	2.24%	33.22%
Inventory
Prepaid Expenses
Receivables	$607.0K	$544.0K	$661.0K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$264.6M	$274.8M	$310.6M
YoY Change	-34.31%	-35.24%	-23.36%
LONG-TERM ASSETS
Property, Plant & Equipment	$38.81M	$39.82M	$40.88M
YoY Change	-8.81%	-7.24%	5.09%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$12.09M	$24.49M	$12.25M
YoY Change		930.42%	-70.63%
Other Assets	$112.0K	$112.0K	$113.0K
YoY Change	0.0%	0.0%	-0.88%
Total Long-Term Assets	$53.04M	$66.45M	$55.27M
YoY Change	18.65%	40.07%	-33.17%
TOTAL ASSETS
Total Short-Term Assets	$264.6M	$274.8M	$310.6M
Total Long-Term Assets	$53.04M	$66.45M	$55.27M
Total Assets	$317.7M	$341.2M	$365.9M
YoY Change	-29.02%	-27.67%	-25.02%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.462M	$3.289M	$4.719M
YoY Change	-62.89%	-1.59%	31.6%
Accrued Expenses	$14.99M	$10.47M	$8.328M
YoY Change	104.0%	60.7%	94.81%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$20.11M	$18.23M	$17.08M
YoY Change	36.08%	39.39%	51.33%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$350.0K	$490.0K	$795.0K
YoY Change	-75.11%	-71.41%	-60.74%
Total Long-Term Liabilities	$350.0K	$490.0K	$795.0K
YoY Change	-75.11%	-71.41%	-60.74%
TOTAL LIABILITIES
Total Short-Term Liabilities	$20.11M	$18.23M	$17.08M
Total Long-Term Liabilities	$350.0K	$490.0K	$795.0K
Total Liabilities	$49.98M	$48.98M	$48.84M
YoY Change	3.04%	2.82%	14.36%
SHAREHOLDERS EQUITY
Retained Earnings	-$364.4M	-$332.2M	-$299.2M
YoY Change	81.61%	98.84%	116.86%
Common Stock	$56.00K	$56.00K	$56.00K
YoY Change	1.82%	1.82%	3.7%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$267.7M	$292.2M	$317.0M
YoY Change
Total Liabilities & Shareholders Equity	$317.7M	$341.2M	$365.9M
YoY Change	-29.02%	-27.67%	-25.02%

Cashflow Statement

Concept	2022 Q3	2022 Q2	2022 Q1
OPERATING ACTIVITIES
Net Income	-$32.26M	-$32.90M	-$36.26M
YoY Change	-4.01%	13.24%	39.01%
Depreciation, Depletion And Amortization	$600.0K	$600.0K	$600.0K
YoY Change	20.0%	20.0%	50.0%
Cash From Operating Activities	-$22.39M	-$22.52M	-$23.48M
YoY Change	11.19%	11.14%	23.61%
INVESTING ACTIVITIES
Capital Expenditures	-$73.00K	-$86.00K	$366.0K
YoY Change	-92.12%	-93.61%	-75.68%
Acquisitions
YoY Change
Other Investing Activities	$3.180M	-$40.64M	-$25.97M
YoY Change	-93.77%	-163.13%	-70.03%
Cash From Investing Activities	$3.107M	-$40.73M	-$26.34M
YoY Change	-93.8%	-164.62%	-70.12%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	628.0K	410.0K	$529.0K
YoY Change	-54.53%	-71.51%	-9.57%
NET CHANGE
Cash From Operating Activities	-22.39M	-22.52M	-$23.48M
Cash From Investing Activities	3.107M	-40.73M	-$26.34M
Cash From Financing Activities	628.0K	410.0K	$529.0K
Net Change In Cash	-18.66M	-62.84M	-$49.29M
YoY Change	-159.55%	-242.14%	-53.74%
FREE CASH FLOW
Cash From Operating Activities	-$22.39M	-$22.52M	-$23.48M
Capital Expenditures	-$73.00K	-$86.00K	$366.0K
Free Cash Flow	-$22.32M	-$22.43M	-$23.85M
YoY Change	16.17%	18.6%	16.32%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Central Index Key EntityCentralIndexKey	0001741830
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-06-30
	dei	Entity File Number EntityFileNumber	001-39592
	dei	Entity Registrant Name EntityRegistrantName	Kronos Bio, Inc.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	82-1895605
	dei	Entity Address Address Line1 EntityAddressAddressLine1	1300 So. El Camino Real
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 400
	dei	Entity Address City Or Town EntityAddressCityOrTown	San Mateo
	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	94402
	dei	City Area Code CityAreaCode	650
	dei	Local Phone Number LocalPhoneNumber	781-5200
	dei	Security12b Title Security12bTitle	Common stock, $0.001 par value per share
	dei	Trading Symbol TradingSymbol	KRON
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	56769091	shares
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	86140000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	198270000	usd
CY2022Q2	us-gaap	Short Term Investments ShortTermInvestments	181749000	usd
CY2021Q4	us-gaap	Short Term Investments ShortTermInvestments	141239000	usd
CY2022Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	6885000	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	8045000	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	274774000	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	347554000	usd
CY2022Q2	us-gaap	Long Term Investments LongTermInvestments	24493000	usd
CY2021Q4	us-gaap	Long Term Investments LongTermInvestments	0	usd
CY2022Q2	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	13985000	usd
CY2021Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	14880000	usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	25830000	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	26904000	usd
CY2022Q2	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	2026000	usd
CY2021Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	2026000	usd
CY2022Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	112000	usd
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	112000	usd
CY2022Q2	us-gaap	Assets Assets	341220000	usd
CY2021Q4	us-gaap	Assets Assets	391476000	usd
CY2022Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	3289000	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	998000	usd
CY2022Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	10471000	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	9063000	usd
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2704000	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2109000	usd
CY2022Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1766000	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	18230000	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	13626000	usd
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1456000	usd
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	30257000	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	31653000	usd
CY2022Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	490000	usd
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1100000	usd
CY2022Q2	us-gaap	Liabilities Liabilities	48977000	usd
CY2021Q4	us-gaap	Liabilities Liabilities	46379000	usd
CY2022Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	56219237	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	56219237	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	55703327	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	55703327	shares
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	56000	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	56000	usd
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q2	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2022Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	624998000	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	608064000	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-332150000	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-262984000	usd
CY2022Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-661000	usd
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-39000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	292243000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	345097000	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	341220000	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	391476000	usd
CY2022Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	22706000	usd
CY2021Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	19802000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	47142000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	37396000	usd
CY2022Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	10824000	usd
CY2021Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	9339000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	22752000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	17923000	usd
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	33530000	usd
CY2021Q2	us-gaap	Operating Expenses OperatingExpenses	29141000	usd
	us-gaap	Operating Expenses OperatingExpenses	69894000	usd
	us-gaap	Operating Expenses OperatingExpenses	55319000	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-33530000	usd
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-29141000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-69894000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-55319000	usd
CY2022Q2	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	627000	usd
CY2021Q2	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	86000	usd
	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	728000	usd
	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	178000	usd
CY2022Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	627000	usd
CY2021Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	86000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-332200000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	728000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	178000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-32903000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-29055000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-69166000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-55141000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-491000	usd
CY2021Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	29000	usd
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-622000	usd
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	25000	usd
CY2022Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-33394000	usd
CY2021Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-29026000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-69788000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-55116000	usd
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.59
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.59
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.53
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.53
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.24
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.24
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.01
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.01
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	56116070	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	56116070	shares
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	54506195	shares
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	54506195	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	55978482	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	55978482	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	54330402	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	54330402	shares
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	345097000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	529000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	7788000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-131000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-36263000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	317020000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	375000	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	8207000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	35000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-491000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-32903000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	292243000	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	465519000	usd
CY2021Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	590000	usd
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	5238000	usd
CY2021Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-4000	usd
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-26086000	usd
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	445257000	usd
CY2021Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	627000	usd
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	6432000	usd
CY2021Q2	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	817000	usd
CY2021Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	29000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-29055000	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	424107000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-69166000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-55141000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1121000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	908000	usd
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-563000	usd
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-2074000	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-765000	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-53000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	15995000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	11670000	usd
	kron	Lease Expense Noncash LeaseExpenseNoncash	1074000	usd
	kron	Lease Expense Noncash LeaseExpenseNoncash	1112000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-823000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	65000	usd
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	0	usd
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-54000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	2287000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1488000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	1638000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	2454000	usd
	kron	Increase Decrease In Right Of Use Operating Assets And Liabilities Net IncreaseDecreaseInRightOfUseOperatingAssetsAndLiabilitiesNet	801000	usd
	kron	Increase Decrease In Right Of Use Operating Assets And Liabilities Net IncreaseDecreaseInRightOfUseOperatingAssetsAndLiabilitiesNet	-172000	usd
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-303000	usd
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-1065000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-46004000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-39262000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	452000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2856000	usd
	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	216117000	usd
	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	141196000	usd
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	149003000	usd
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	118933000	usd
	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	501000	usd
	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	0	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-67065000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-25119000	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	0	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	5000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	904000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1217000	usd
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans	35000	usd
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans	817000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	939000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2029000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-112130000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-62352000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	200296000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	250036000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	88166000	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	187684000	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	0	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	648000	usd
	kron	Right Of Use Asset Increase Decrease Due To Modification RightOfUseAssetIncreaseDecreaseDueToModification	0	usd
	kron	Right Of Use Asset Increase Decrease Due To Modification RightOfUseAssetIncreaseDecreaseDueToModification	-1741000	usd
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	86140000	usd
CY2021Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	185658000	usd
CY2022Q2	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	2026000	usd
CY2021Q2	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	2026000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	88166000	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	187684000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting periods. Significant estimates and assumptions reflected in these condensed financial statements include, but are not limited to, the accrual of research and development expenses, the fair value of investments, income tax uncertainties, the valuation of equity instruments and the incremental borrowing rate for determining the operating lease assets and liabilities. Estimates are periodically reviewed in light of changes in circumstances, facts and experience. Actual results could differ from the Company’s estimates.</span></div>
CY2022Q2	kron	Cash And Cash Equivalent And Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest After Allowance For Credit Loss CashAndCashEquivalentAndDebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss	285001000	usd
CY2022Q2	kron	Cash And Cash Equivalent And Debt Securities Available For Sale Gross Unrealized Gain Before Tax CashAndCashEquivalentAndDebtSecuritiesAvailableForSaleGrossUnrealizedGainBeforeTax	2000	usd
CY2022Q2	kron	Cash And Cash Equivalent And Debt Securities Available For Sale Gross Unrealized Loss Before Tax CashAndCashEquivalentAndDebtSecuritiesAvailableForSaleGrossUnrealizedLossBeforeTax	663000	usd
CY2022Q2	kron	Cash And Cash Equivalent And Debt Securities Available For Sale Excluding Accrued Interest CashAndCashEquivalentAndDebtSecuritiesAvailableForSaleExcludingAccruedInterest	284340000	usd
CY2021Q4	kron	Cash And Cash Equivalent And Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest After Allowance For Credit Loss CashAndCashEquivalentAndDebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss	331976000	usd
CY2021Q4	kron	Cash And Cash Equivalent And Debt Securities Available For Sale Gross Unrealized Gain Before Tax CashAndCashEquivalentAndDebtSecuritiesAvailableForSaleGrossUnrealizedGainBeforeTax	2000	usd
CY2021Q4	kron	Cash And Cash Equivalent And Debt Securities Available For Sale Gross Unrealized Loss Before Tax CashAndCashEquivalentAndDebtSecuritiesAvailableForSaleGrossUnrealizedLossBeforeTax	41000	usd
CY2021Q4	kron	Cash And Cash Equivalent And Debt Securities Available For Sale Excluding Accrued Interest CashAndCashEquivalentAndDebtSecuritiesAvailableForSaleExcludingAccruedInterest	331937000	usd
CY2022Q2	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	78098000	usd
CY2021Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	190698000	usd
CY2022Q2	us-gaap	Short Term Investments ShortTermInvestments	181749000	usd
CY2021Q4	us-gaap	Short Term Investments ShortTermInvestments	141239000	usd
CY2022Q2	us-gaap	Long Term Investments LongTermInvestments	24493000	usd
CY2021Q4	us-gaap	Long Term Investments LongTermInvestments	0	usd
CY2022Q2	us-gaap	Investments And Cash InvestmentsAndCash	284340000	usd
CY2021Q4	us-gaap	Investments And Cash InvestmentsAndCash	331937000	usd
CY2022Q2	us-gaap	Available For Sale Securities Debt Maturities Next Rolling Twelve Months Fair Value AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue	259847000	usd
CY2021Q4	us-gaap	Available For Sale Securities Debt Maturities Next Rolling Twelve Months Fair Value AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue	143014000	usd
CY2022Q2	us-gaap	Available For Sale Securities Debt Maturities Rolling Year Two Through Five Fair Value AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue	24493000	usd
CY2021Q4	us-gaap	Available For Sale Securities Debt Maturities Rolling Year Two Through Five Fair Value AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue	0	usd
CY2022Q2	us-gaap	Available For Sale Securities Debt Maturities Without Single Maturity Date Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue	0	usd
CY2021Q4	us-gaap	Available For Sale Securities Debt Maturities Without Single Maturity Date Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue	188923000	usd
CY2022Q2	us-gaap	Investments And Cash InvestmentsAndCash	284340000	usd
CY2021Q4	us-gaap	Investments And Cash InvestmentsAndCash	331937000	usd
CY2021	us-gaap	Other Than Temporary Impairment Loss Debt Securities Available For Sale OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale	0	usd
	us-gaap	Other Than Temporary Impairment Loss Debt Securities Available For Sale OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale	0	usd
CY2022Q2	kron	Debt Securities Available For Sale Accrued Interest DebtSecuritiesAvailableForSaleAccruedInterest	544000	usd
CY2021Q4	kron	Debt Securities Available For Sale Accrued Interest DebtSecuritiesAvailableForSaleAccruedInterest	816000	usd
CY2022Q2	kron	Prepaid Equipment Service Contracts PrepaidEquipmentServiceContracts	395000	usd
CY2021Q4	kron	Prepaid Equipment Service Contracts PrepaidEquipmentServiceContracts	360000	usd
CY2022Q2	kron	Prepaid External Research And Development And Outside Services PrepaidExternalResearchAndDevelopmentAndOutsideServices	3198000	usd
CY2021Q4	kron	Prepaid External Research And Development And Outside Services PrepaidExternalResearchAndDevelopmentAndOutsideServices	3074000	usd
CY2022Q2	kron	Prepaid Software PrepaidSoftware	914000	usd
CY2021Q4	kron	Prepaid Software PrepaidSoftware	624000	usd
CY2022Q2	us-gaap	Prepaid Insurance PrepaidInsurance	969000	usd
CY2021Q4	us-gaap	Prepaid Insurance PrepaidInsurance	2644000	usd
CY2022Q2	us-gaap	Prepaid Rent PrepaidRent	865000	usd
CY2021Q4	us-gaap	Prepaid Rent PrepaidRent	527000	usd
CY2022Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	6885000	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	8045000	usd
CY2022Q2	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization	18366000	usd
CY2021Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization	18139000	usd
CY2022Q2	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	4381000	usd
CY2021Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	3259000	usd
CY2022Q2	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	13985000	usd
CY2021Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	14880000	usd
CY2022Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	600000	usd
CY2021Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	500000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1100000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	900000	usd
CY2022Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	2562000	usd
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	4570000	usd
CY2022Q2	kron	Accrued External Research And Development Current AccruedExternalResearchAndDevelopmentCurrent	7046000	usd
CY2021Q4	kron	Accrued External Research And Development Current AccruedExternalResearchAndDevelopmentCurrent	2655000	usd
CY2022Q2	kron	Accrued Outside Services Current AccruedOutsideServicesCurrent	843000	usd
CY2021Q4	kron	Accrued Outside Services Current AccruedOutsideServicesCurrent	1598000	usd
CY2022Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	20000	usd
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	240000	usd
CY2022Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	10471000	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	9063000	usd
CY2022Q2	us-gaap	Deferred Compensation Share Based Arrangements Liability Current DeferredCompensationShareBasedArrangementsLiabilityCurrent	1220000	usd
CY2021Q4	us-gaap	Deferred Compensation Share Based Arrangements Liability Current DeferredCompensationShareBasedArrangementsLiabilityCurrent	1364000	usd
CY2022Q2	kron	Espp Withholdings Liability Current ESPPWithholdingsLiabilityCurrent	546000	usd
CY2021Q4	kron	Espp Withholdings Liability Current ESPPWithholdingsLiabilityCurrent	92000	usd
CY2022Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1766000	usd
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1456000	usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	6590400	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	14.33
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	2189700	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	6.90
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	164853	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	13.07
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	379645	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	2.37
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	8235602	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	12.93
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y6M29D
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	2164000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	4.69
CY2022Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	48800000	usd
CY2021Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	49900000	usd
CY2022Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	8207000	usd
CY2021Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	6432000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	15995000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	11670000	usd
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2021Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-32903000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-29055000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-69166000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-55141000	usd
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	56116070	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	56116070	shares
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	54506195	shares
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	54506195	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	55978482	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	55978482	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	54330402	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	54330402	shares
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.59
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.59
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.53
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.53
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.24
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.24
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.01
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.01
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	9724413	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	8065895	shares
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	25830000	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	26904000	usd
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2704000	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2109000	usd
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	30257000	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	31653000	usd
CY2022Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	32961000	usd
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	33762000	usd
CY2022Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	1278000	usd
CY2021Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	1380000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	2555000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	2764000	usd
CY2022Q2	us-gaap	Operating Lease Payments OperatingLeasePayments	1200000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	2300000	usd
CY2021Q2	us-gaap	Operating Lease Payments OperatingLeasePayments	1200000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	2300000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	2734000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1792000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	5749000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	5921000	usd
CY2022Q2	kron	Lessee Operating Lease Liability To Be Paid Year Four And Thereafter LesseeOperatingLeaseLiabilityToBePaidYearFourAndThereafter	26709000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	42905000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	9944000	usd
CY2022Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	32961000	usd

Files In Submission

Name	View Source	Status
0001741830-22-000026-index-headers.html	Edgar Link	pending
0001741830-22-000026-index.html	Edgar Link	pending
0001741830-22-000026.txt	Edgar Link	pending
0001741830-22-000026-xbrl.zip	Edgar Link	pending
a10.htm	Edgar Link	pending
a10001.jpg	Edgar Link	pending
a10002.jpg	Edgar Link	pending
a10003.jpg	Edgar Link	pending
a10004.jpg	Edgar Link	pending
a10005.jpg	Edgar Link	pending
a10006.jpg	Edgar Link	pending
a10007.jpg	Edgar Link	pending
a10008.jpg	Edgar Link	pending
a10009.jpg	Edgar Link	pending
a10010.jpg	Edgar Link	pending
a10011.jpg	Edgar Link	pending
a10012.jpg	Edgar Link	pending
a10013.jpg	Edgar Link	pending
a10014.jpg	Edgar Link	pending
a10015.jpg	Edgar Link	pending
a10016.jpg	Edgar Link	pending
a10017.jpg	Edgar Link	pending
compensationcommitteecon.htm	Edgar Link	pending
compensationcommitteecon001.jpg	Edgar Link	pending
compensationcommitteecon002.jpg	Edgar Link	pending
compensationcommitteecon003.jpg	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
kron-20220630.htm	Edgar Link	pending
kron-20220630.xsd	Edgar Link	pending
kron-20220630_cal.xml	Edgar Link	unprocessable
kron-20220630_def.xml	Edgar Link	unprocessable
kron-20220630_g1.jpg	Edgar Link	pending
kron-20220630_htm.xml	Edgar Link	completed
kron-20220630_lab.xml	Edgar Link	unprocessable
kron-20220630_pre.xml	Edgar Link	unprocessable
kronq2fy2022ex311.htm	Edgar Link	pending
kronq2fy2022ex312.htm	Edgar Link	pending
kronq2fy2022ex321.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$KRON
Kronos Bio, Inc. Stock $kron

2022 Q3 Form 10-Q Financial Statement

#000174183022000026 Filed on August 04, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KRON Kronos Bio, Inc. Stock $kron

2022 Q3 Form 10-Q Financial Statement

#000174183022000026 Filed on August 04, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KRON
Kronos Bio, Inc. Stock $kron